PRE-IMPLANTATION GENETIC DIAGNOSIS USING POLAR BODIES
Tomi D1,*, Voigt R1, Eckhold J1, Hinrichs F1, Griesinger G2, Shulze-Mosgau A2, Schöpper B2, Al-Hasani S2, Diedrich K2, Schwinger E1
*Corresponding Author: Dr. Diana Tomi, Institute of Human Genetics, Medical University of Lübeck, Ratze¬burger Allee 160, 23538 Lübeck, Germany; Tel.: +49(0)451-500-2621; Fax: +49(0)451-500-4187; E-mail: dianatomi@hotmail.com
page: 17

INTRODUCTION

Pre-implantation genetic diagnosis (PGD) offers high-risk couples for genetic diseases in their offspring the option of detecting these diseases before implantation of the embryos. By analyzing the polar bodies (PBs) manipu­lation of the embryo itself is avoided [1].

This is also the only possibility of performing PGD in Germany due to the “Embryo Protection Law” (Embryo­nenschutzgesetz) [2,3]. Termination of pregnancy after prenatal diagnosis is accepted and practised in Germany. However, some couples refuse pregnancy interruption so that PB diagnosis is considered as an alternative. The limitation of PB diagnosis is that one can only test one cell and analyze only the maternal genome.

Cystic fibrosis (CF) is the most common severe auto­somal recessive disease in the Caucasian population, af­fecting about 1 in 2,500 newborns. The most predominant defect, accounting for 70-75% of all CF mutations in North Europe, is a 3 bp deletion at amino acid position 508 (DF508). At the present time, more than 900 different mutations in the CF transmembrane conductance regulator gene (CFTR) have been reported. To make pre-implanta­tion diagnosis reliable for affected couples and compatible with the restrictions by the German law, we established a multiplex polymerase chain reaction (PCR) assay for PB testing.

Chromosomal aneuploidy is the most frequent cause for loss of pregnancies [4]. Early pregnancy losses, without the possibility of analyzing the embryonal karyotype, may also be caused, to a considerable degree, by aneuploidy. By fluorescent in situ hybridization (FISH) using specific fluorochrome-labelled DNA probes for different chromo­somes, it is possible to evaluate the number of the marked chromosomes in interphase cells. Fluorescent in situ hy­bridization was used for the first time to detect sex chro­mosomes in human blastomeres [5]. This technique was expanded to detect aneuploidies for three or more chromo­somes in blastomeres and also in PBs [6,7]. We present our first data after first PB diagnosis for aneuploidies of chromosomes 15, 16 and 22.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006